MGMT and central nervous system cancer: In conclusion, QX302 demonstrates potent anti-glioma activity by inducing DNA alkylation and cross-linking, even in MGMT-positive cells, leading to DNA damage, cell cycle arrest, ferroptosis and apoptosis.